Recruiting at 1 site Phase 4 Glaucoma, Open-angle

Glaucoma, Open-angle study: IDose TR

Official title Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone

ClinicalTrials.gov ID: NCT06848946

What this study is testing

What is iDose TR (travoprost intracameral implant) 75 µg?

an investigational implant placed inside the eye during cataract surgery that is being studied as a potential treatment for open-angle glaucoma or ocular hypertension. is designed to release travoprost, a prostaglandin analog that increases fluid outflow from the eye to lower pressure.

Also referred to as travoprost.

Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The study aims to find out if the iDose TR implant is safe and lowers eye pressure better than cataract surgery by itself.
Who it's for
Adults who have open‑angle glaucoma or ocular hypertension and are scheduled for cataract surgery.
What's involved
Participants will have cataract surgery; some will also receive the iDose TR implant placed in the eye during the operation, and all will have regular eye‑pressure checks and safety exams.
Time commitment
Follow‑up visits for several months after surgery to monitor eye pressure and safety.
  • Phase 4: studies an already-approved treatment
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 45 and older

You may be able to join if

  • Cataract diagnosis: clinically significant age-related cataract eligible for phacoemulsification in the study eye.
  • OAG or OHT diagnosis: either OAG (i.e. primary, pseudoexfoliation, or pigmentary glaucoma) or OHT in the study eye (i.e., eye to undergo cataract...

You likely can't join if

  • Active corneal inflammation or edema.
  • Retinal disorders not associated with glaucoma.

The study team makes the final eligibility decision.

Where it is enrolling

  • Kenosha, Wisconsin, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 45 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Kenosha, Wisconsin, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.